Ameridose Recalls Products After FDA Investigation

A second Massachusetts compounding pharmacy, Ameridose, has recalled products in the wake of a meningitis outbreak linked to the New England Compounding Center pharmacy, according to a WebMD report.

Advertisement

No cases of meningitis have been linked to Ameridose and an FDA investigation of the company hasn’t found evidence to suggest contamination. However, the FDA did ask Ameridose to improve its sterility process, and the company will post recalled products on its website.

More Articles on Pain Management:

Early Physical Therapy for Low Back Pain Saves Healthcare Dollars

Dr. Vladimir Redko Joins North American Spine

Washington Center for Pain Management to Expand

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.